BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the target of a large increase in short interest in May. As of May 29th, there was short interest totaling 101,894 shares, an increase of 119.6% from the May 14th total of 46,393 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 3,318 shares, the days-to-cover ratio is currently 30.7 days.
BioNxt Solutions Price Performance
Shares of BNXTF stock opened at $0.25 on Friday. The stock’s fifty day simple moving average is $0.33 and its 200 day simple moving average is $0.40. The firm has a market cap of $31.09 million, a price-to-earnings ratio of -5.08 and a beta of 0.64. BioNxt Solutions has a one year low of $0.14 and a one year high of $0.80.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last announced its quarterly earnings results on Friday, May 29th. The company reported ($0.01) EPS for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Featured Stories
- Five stocks we like better than BioNxt Solutions
- TJX: Retail’s Apex Predator Feasts on Inflation
- MarketBeat Week in Review – 06/08 – 06/12
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
